BCYC
Price
$24.80
Change
+$0.25 (+1.02%)
Updated
Mar 28, 1:57 PM EST
35 days until earnings call
IMTX
Price
$10.70
Change
-$0.40 (-3.60%)
Updated
Mar 28, 2:08 PM EST
47 days until earnings call
Ad is loading...

Compare trend and price BCYC vs IMTX

Header iconBCYC vs IMTX Comparison
Open Charts BCYC vs IMTXBanner chart's image
Bicycle Therapeutics
Price$24.80
Change+$0.25 (+1.02%)
Volume$100
CapitalizationN/A
Immatics
Price$10.70
Change-$0.40 (-3.60%)
Volume$11K
CapitalizationN/A
View a ticker or compare two or three
BCYC vs IMTX Comparison Chart

Loading...

BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
IMTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BCYC vs. IMTX commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and IMTX is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (BCYC: $24.55 vs. IMTX: $11.10)
Brand notoriety: BCYC and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 82% vs. IMTX: 198%
Market capitalization -- BCYC: $929.96M vs. IMTX: $1.14B
BCYC [@Biotechnology] is valued at $929.96M. IMTX’s [@Biotechnology] market capitalization is $1.14B. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 0 FA rating(s) are green whileIMTX’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 0 green, 5 red.
  • IMTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BCYC is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while IMTX’s TA Score has 3 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 5 bearish.
  • IMTX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than IMTX.

Price Growth

BCYC (@Biotechnology) experienced а -4.14% price change this week, while IMTX (@Biotechnology) price change was -7.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +5.11%, and the average quarterly price growth was +88.96%.

Reported Earning Dates

BCYC is expected to report earnings on May 02, 2024.

IMTX is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCYC with price predictions.
OPEN
A.I.dvisor published
a Summary for IMTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
IMTX($1.14B) has a higher market cap than BCYC($930M). BCYC YTD gains are higher at: 35.785 vs. IMTX (5.413). IMTX has higher annual earnings (EBITDA): -88.93M vs. BCYC (-169.4M). BCYC has more cash in the bank: 526M vs. IMTX (426M). IMTX has less debt than BCYC: IMTX (15.4M) vs BCYC (45M). IMTX has higher revenues than BCYC: IMTX (54M) vs BCYC (27M).
BCYCIMTXBCYC / IMTX
Capitalization930M1.14B81%
EBITDA-169.4M-88.93M190%
Gain YTD35.7855.413661%
P/E RatioN/A16.39-
Revenue27M54M50%
Total Cash526M426M123%
Total Debt45M15.4M292%
TECHNICAL ANALYSIS
Technical Analysis
BCYCIMTX
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
51%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 7 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 7 days ago
74%
View a ticker or compare two or three
Ad is loading...
BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
IMTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJIQX13.470.16
+1.20%
PGIM Jennison Global Equity Income R6
PRWAX72.580.26
+0.36%
T. Rowe Price All-Cap Opportunities Fund
PEPSX25.390.04
+0.16%
Principal Glb Emerging Markets R5
GEORX5.77N/A
N/A
Pear Tree Essex Environmental Opps R6
AEDMX10.85N/A
N/A
American Century Emerging Markets R6

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PHIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+0.08%
PHIO - BCYC
41%
Loosely correlated
-1.37%
MLTX - BCYC
39%
Loosely correlated
+0.20%
ABUS - BCYC
37%
Loosely correlated
+4.02%
ORMP - BCYC
35%
Loosely correlated
+4.41%
SAGE - BCYC
34%
Loosely correlated
+2.42%
More

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IMCR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IMCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-2.37%
IMCR - IMTX
41%
Loosely correlated
+2.98%
KNSA - IMTX
36%
Loosely correlated
+0.10%
INBX - IMTX
36%
Loosely correlated
+0.23%
RVMD - IMTX
35%
Loosely correlated
+5.73%
PRME - IMTX
34%
Loosely correlated
+1.65%
More